InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

TGTX Insider Trading

Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $1,013,000.00
Insider Selling (Last 12 Months): $4,274,708.85

TG Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at TG Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TG Therapeutics Share Price & Price History

Current Price: $13.78
Price Change: ▼ Price Decrease of -0.21 (-1.50%)
As of 04/19/2024 01:00 AM ET

This chart shows the closing price history over time for TGTX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The “Perfect Storm” for Gold
From Gold Safe Exchange   |   Ad
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Click here now to download the free Precious Metals Buying Guide!

TG Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2024Laurence N. CharneyDirectorSell22,000$15.97$351,340.00215,229View SEC Filing Icon  
1/5/2024Laurence N. CharneyDirectorSell17,500$19.03$333,025.00237,229View SEC Filing Icon  
1/3/2024Sean A. PowerCFOSell47,867$16.91$809,430.97606,969View SEC Filing Icon  
8/11/2023Michael S. WeissCEOBuy100,000$10.13$1,013,000.0012,073,021View SEC Filing Icon  
6/23/2023Sagar LonialDirectorSell34,854$23.37$814,537.9893,878View SEC Filing Icon  
6/2/2023Sean A. PowerCFOSell73,647$26.70$1,966,374.90654,836View SEC Filing Icon  
1/6/2023Yann EchelardDirectorBuy9,000$10.64$95,760.00201,848View SEC Filing Icon  
1/4/2023Laurence N. CharneyDirectorSell30,000$11.10$333,000.00234,729View SEC Filing Icon  
1/4/2022Michael S. WeissCEOSell37,549$19.20$720,940.80View SEC Filing Icon  
1/4/2022Sean A. PowerCFOSell75,312$19.20$1,445,990.40View SEC Filing Icon  
See Full Table
The “Perfect Storm” for Gold
From Gold Safe Exchange   |   Ad
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Click here now to download the free Precious Metals Buying Guide!

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TGTX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TG Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/17/2024Hennion & Walsh Asset Management Inc.184,815$2.81M0.2%+16.9%0.120%Search for SEC Filing on Google Icon
4/11/2024Capital CS Group LLC17,525$0.27M0.3%-37.7%0.011%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC76,616$1.17M0.0%+55.8%0.050%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.13,670,944$233.50M0.0%+1.5%9.029%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP3,139,764$53.63M0.0%+1.4%2.074%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.1,649,837$28.18M0.0%-2.4%1.090%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC439,474$7.51M0.1%N/A0.290%Search for SEC Filing on Google Icon
2/17/2024FIL Ltd43,226$0.74M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/16/2024Price T Rowe Associates Inc. MD80,588$1.38M0.0%+51.1%0.053%Search for SEC Filing on Google Icon
2/15/2024Exome Asset Management LLC203,300$3.47M3.4%N/A0.134%Search for SEC Filing on Google Icon
2/15/2024Virtus ETF Advisers LLC5,143$88K0.1%+41.5%0.003%Search for SEC Filing on Google Icon
2/15/2024Legal & General Group Plc147,098$2.51M0.0%+8.4%0.097%Search for SEC Filing on Google Icon
2/15/2024Barclays PLC428,013$7.31M0.0%-2.2%0.283%Search for SEC Filing on Google Icon
2/15/2024Vanguard Group Inc.13,670,944$233.50M0.0%+1.5%9.029%Search for SEC Filing on Google Icon
2/15/2024Voya Investment Management LLC54,988$0.94M0.0%-74.7%0.036%Search for SEC Filing on Google Icon
2/15/2024Weiss Multi Strategy Advisers LLC60,000$1.03M0.0%+41.6%0.040%Search for SEC Filing on Google Icon
2/15/2024Nuveen Asset Management LLC1,350,721$23.07M0.0%+253.5%0.892%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.2,215,000$37.83M10.1%+17.2%1.463%Search for SEC Filing on Google Icon
2/15/2024Prelude Capital Management LLC48,800$0.83M0.1%-16.9%0.032%Search for SEC Filing on Google Icon
2/15/2024Price T Rowe Associates Inc. MD80,588$1.38M0.0%+51.1%0.053%Search for SEC Filing on Google Icon
2/15/2024Profund Advisors LLC93,489$1.60M0.1%-34.9%0.062%Search for SEC Filing on Google Icon
2/15/2024Parkman Healthcare Partners LLC205,317$3.51M0.5%-1.9%0.136%Search for SEC Filing on Google Icon
2/15/2024Parkwood LLC24,347$0.42M0.0%-85.3%0.016%Search for SEC Filing on Google Icon
2/15/2024Gotham Asset Management LLC96,250$1.64M0.0%+34.8%0.064%Search for SEC Filing on Google Icon
2/15/2024Baird Financial Group Inc.39,478$0.67M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/15/2024Bayesian Capital Management LP116,067$1.98M0.2%N/A0.077%Search for SEC Filing on Google Icon
2/14/2024Royal Bank of Canada63,146$1.08M0.0%+49.6%0.042%Search for SEC Filing on Google Icon
2/14/2024Kestra Advisory Services LLC23,761$0.41M0.0%+45.4%0.016%Search for SEC Filing on Google Icon
2/14/2024Creative Planning28,805$0.49M0.0%+12.4%0.019%Search for SEC Filing on Google Icon
2/14/2024Putnam Investments LLC41,401$0.71M0.0%+21.7%0.027%Search for SEC Filing on Google Icon
2/14/2024Balyasny Asset Management L.P.425,099$7.26M0.0%+190.5%0.281%Search for SEC Filing on Google Icon
2/14/2024Lighthouse Investment Partners LLC76,729$1.31M0.1%N/A0.051%Search for SEC Filing on Google Icon
2/14/2024Verition Fund Management LLC14,104$0.24M0.0%-73.4%0.009%Search for SEC Filing on Google Icon
2/13/2024Envestnet Asset Management Inc.46,707$0.80M0.0%+13.0%0.031%Search for SEC Filing on Google Icon
2/13/2024Northern Trust Corp1,350,935$23.07M0.0%-0.5%0.892%Search for SEC Filing on Google Icon
2/13/2024Public Employees Retirement Association of Colorado17,253$0.30M0.0%+138.9%0.011%Search for SEC Filing on Google Icon
2/13/2024Cetera Advisor Networks LLC42,290$0.72M0.0%+147.9%0.028%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 8,036$0.14M0.0%+39.9%0.005%Search for SEC Filing on Google Icon
2/13/2024First Trust Advisors LP38,567$0.66M0.0%-72.8%0.025%Search for SEC Filing on Google Icon
2/13/2024Goldman Sachs Group Inc.1,649,837$28.18M0.0%-2.4%1.090%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC571,126$9.76M0.0%-33.3%0.377%Search for SEC Filing on Google Icon
2/13/2024The Manufacturers Life Insurance Company 70,215$1.20M0.0%-1.7%0.046%Search for SEC Filing on Google Icon
2/13/2024KBC Group NV3,146$54K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System150,578$2.57M0.0%-3.3%0.099%Search for SEC Filing on Google Icon
2/12/2024Pingora Partners LLC1,600$27K0.0%N/A0.001%Search for SEC Filing on Google Icon
2/9/2024US Bancorp DE5,087$87K0.0%+1,064.1%0.003%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.64,926$1.11M0.0%+87.6%0.043%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP350,218$5.98M0.1%-10.3%0.231%Search for SEC Filing on Google Icon
2/9/2024Corient Private Wealth LLC93,381$1.60M0.0%+231.6%0.062%Search for SEC Filing on Google Icon
2/9/2024UBS Group AG564,836$9.65M0.0%+67.2%0.373%Search for SEC Filing on Google Icon
2/9/2024Norges Bank1,075,037$18.36M0.0%N/A0.710%Search for SEC Filing on Google Icon
2/7/2024Private Portfolio Partners LLC11,750$0.20M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/7/2024NBC Securities Inc.9,401$0.16M0.0%+34.5%0.006%Search for SEC Filing on Google Icon
2/7/2024Dana Investment Advisors Inc.20,754$0.35M0.0%-63.9%0.014%Search for SEC Filing on Google Icon
2/7/2024BNP Paribas Financial Markets293,607$5.02M0.0%-74.9%0.194%Search for SEC Filing on Google Icon
2/7/2024Teacher Retirement System of Texas33,117$0.57M0.0%-17.4%0.022%Search for SEC Filing on Google Icon
2/7/2024E Fund Management Co. Ltd.30,553$0.52M0.0%-30.6%0.020%Search for SEC Filing on Google Icon
2/6/2024Charles Schwab Investment Management Inc.1,131,896$19.33M0.0%+1.7%0.748%Search for SEC Filing on Google Icon
2/6/2024Private Advisor Group LLC13,634$0.23M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/6/2024Amalgamated Bank19,799$0.34M0.0%-4.4%0.013%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank282,600$4.83M0.0%-9.4%0.187%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.18,522$0.32M0.0%+22.7%0.012%Search for SEC Filing on Google Icon
2/5/2024Avaii Wealth Management LLC29,283$0.50M0.3%-13.9%0.019%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.22,416$0.38M0.0%-6.8%0.015%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund56,208$0.96M0.0%+1.2%0.037%Search for SEC Filing on Google Icon
2/1/2024Handelsbanken Fonder AB33,200$0.57M0.0%+48.9%0.022%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank 33,742$0.58M0.0%+27.8%0.022%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio17,500$0.30M0.0%N/A0.012%Search for SEC Filing on Google Icon
1/29/2024Wealth Effects LLC14,000$0.24M0.1%-9.7%0.009%Search for SEC Filing on Google Icon
1/29/2024Valeo Financial Advisors LLC63,300$1.08M0.0%+2.4%0.042%Search for SEC Filing on Google Icon
1/25/2024Allspring Global Investments Holdings LLC1,716$29K0.0%-89.2%0.001%Search for SEC Filing on Google Icon
1/25/2024Nisa Investment Advisors LLC5,180$88K0.0%-89.7%0.003%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.81,181$1.39M0.0%-5.1%0.054%Search for SEC Filing on Google Icon
1/24/2024Stratos Wealth Partners LTD.17,755$0.30M0.0%+70.2%0.012%Search for SEC Filing on Google Icon
1/24/2024Clear Creek Financial Management LLC19,350$0.33M0.1%-3.7%0.013%Search for SEC Filing on Google Icon
1/19/2024Signature Wealth Management Partners LLC10,780$0.18M0.2%N/A0.007%Search for SEC Filing on Google Icon
1/17/2024Trust Co of the South10,600$0.18M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/16/2024Raymond James Financial Services Advisors Inc.102,872$1.76M0.0%+4.1%0.068%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates126,442$2.16M0.0%-15.8%0.084%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC20,219$0.35M0.0%N/A0.013%Search for SEC Filing on Google Icon
1/11/2024Brookstone Capital Management16,867$0.29M0.0%-3.9%0.011%Search for SEC Filing on Google Icon
1/10/2024North Star Investment Management Corp.30,400$0.52M0.0%+590.9%0.020%Search for SEC Filing on Google Icon
1/2/2024Anchor Investment Management LLC4,700$80K0.0%N/A0.003%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.13,471,174$112.62M0.0%+0.1%8.897%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP3,096,474$25.89M0.0%-2.0%2.045%Search for SEC Filing on Google Icon
11/24/2023Deutsche Bank AG93,537$0.78M0.0%-2.5%0.062%Search for SEC Filing on Google Icon
11/22/2023Graham Capital Management L.P.19,065$0.16M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.405,618$3.39M0.0%+56.0%0.268%Search for SEC Filing on Google Icon
11/16/2023Creative Planning25,624$0.21M0.0%-5.4%0.017%Search for SEC Filing on Google Icon
11/16/2023Tudor Investment Corp Et Al94,660$0.79M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/15/2023The Manufacturers Life Insurance Company 71,439$0.60M0.0%+2.3%0.047%Search for SEC Filing on Google Icon
11/15/2023Dana Investment Advisors Inc.57,559$0.48M0.0%+57.1%0.038%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP22,857$0.19M0.0%-68.0%0.015%Search for SEC Filing on Google Icon
11/15/2023Royal Bank of Canada42,201$0.35M0.0%+36.7%0.028%Search for SEC Filing on Google Icon
11/15/2023Legal & General Group Plc135,714$1.14M0.0%+1.7%0.090%Search for SEC Filing on Google Icon
11/15/2023Ameriprise Financial Inc.63,058$0.53M0.0%-12.1%0.042%Search for SEC Filing on Google Icon
11/15/2023Advisors Asset Management Inc.7,380$62K0.0%+208.9%0.005%Search for SEC Filing on Google Icon
11/15/2023AQR Capital Management LLC59,855$0.50M0.0%-5.9%0.040%Search for SEC Filing on Google Icon
11/14/2023Lazard Asset Management LLC6,736$56K0.0%N/A0.004%Search for SEC Filing on Google Icon
11/14/2023683 Capital Management LLC1,350,000$11.29M0.9%N/A0.892%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TG Therapeutics logo
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.
Read More on TG Therapeutics

Today's Range

Now: $13.78
Low: $13.26
High: $14.01

50 Day Range

MA: $15.13
Low: $13.02
High: $18.23

52 Week Range

Now: $13.78
Low: $6.46
High: $35.67

Volume

3,665,965 shs

Average Volume

4,188,957 shs

Market Capitalization

$2.13 billion

P/E Ratio

689.34

Dividend Yield

N/A

Beta

2.3

Who are the company insiders with the largest holdings of TG Therapeutics?

TG Therapeutics' top insider investors include:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
  3. Laurence N Charney (Director)
  4. Yann Echelard (Director)
  5. Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.

Who are the major institutional investors of TG Therapeutics?

TG Therapeutics' top institutional shareholders include:
  1. Hennion & Walsh Asset Management Inc. — 0.12%
  2. Los Angeles Capital Management LLC — 0.05%
  3. Capital CS Group LLC — 0.01%
Learn More about top institutional investors of TG Therapeutics stock.

Which institutional investors are selling TG Therapeutics stock?

In the previous quarter, TGTX stock was sold by these institutional investors:
  1. Capital CS Group LLC
In the previous year, company insiders that have sold TG Therapeutics company stock include:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
  3. Laurence N Charney (Director)
Learn More investors selling TG Therapeutics stock.

Which institutional investors are buying TG Therapeutics stock?

In the last quarter, TGTX stock was bought by institutional investors including:
  1. Los Angeles Capital Management LLC
  2. Hennion & Walsh Asset Management Inc.
Within the previous year, these company insiders have bought TG Therapeutics stock:
  1. Michael S Weiss (CEO)
  2. Sean A Power (CFO)
Learn More investors buying TG Therapeutics stock.
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>